Essex Investment Management CO LLC Bei Gene, Ltd. Transaction History

Essex Investment Management CO LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$122.82 - $151.83 $1.34 Million - $1.65 Million	-10,896 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$107.01 - $175.15 $796,475 - $1.3 Million	7,443 Added 215.55%	10,896 $1.53 Million
Q3 2018 Oct 16, 2018	BUY	$152.62 - $189.66 $526,996 - $654,895	3,453 New	3,453 $595,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.